2. Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 3. Manohar P, et al. Updates...
This is also called metastatic breast cancer, where cancer spreads to multiple organs of the body such as the brain, bones, lungs, and liver, etc. From:Targeted Nanomedicine for Breast Cancer Therapy,2022 About this page Set alert Also in subject areas: ...
METASTATIC breast cancerMICROSOFT Corp.CYCLIN-dependent kinase inhibitorsBREAST cancerHORMONE receptor positive breast cancerBackground: MBC is a lethal form of breast cancer that arises when cancer cells invade other organs or tissues. The treatment of MBC needs personalized approaches...
Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking George D. Cresswell, Daniel Nichol, Inmaculada Spiteri, Haider Tari, Luis Zapata, Timon Heide, Carlo C. Maley, Luca Magnani, Gaia Schiavon, Alan Ashworth, Peter Barry & Andrea Sot...
Despite being the hallmark of cancer that is responsible for the highest number of deaths, very little is known about the biology of metastasis. Metastatic disease typically manifests after a protracted period of undetectable disease following surgery or systemic therapy, owing to relapse or recurrence...
This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population-based data on incidence, mortality, survival, and mammography screen...
Cancer Statistics reported the incidence of breast cancer at 30%, ranking first in female carcinoma incidence; the mortality rate of breast cancer was 14%, ranking second for female tumor mortality in the United States in 2017 [1]. The treatment of breast cancer has entered an evidence-based ...
Metastatic Breast Cancer Treated with Lapatinib with a Prolonged Benefit: A Case Report and a Review of Therapeutic Options AvailableA 53-year-old woman was treated, after trastuzumab progression of HER2-positive metastatic disease, with ... Giulia,Valeria,Bianchi,... - 《Tumori Journal》 被引量...
The study also showed that the silencing of ZBP1 increases cancer cells' ability to migrate and promotes the proliferation of metastatic cells. The findings have important implications for forecasting breast cancer outcomes. According to the researchers, signs of ZBP1 silencing in breast cancer cells...
Berkeley Electronic Press Selected WorksBackground: Many researchers are interested to know if there are any improvements in recent treatment results for metastatic breast cancer in the community, especially for 10- or 15-year survival. Methods: Between 1981 and 1985, 782 and 580 female patients wi...